EMD LEXIGEN

USPTO USPTO 2001 ABANDONED - AFTER EX PARTE APPEAL

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The US trademark EMD LEXIGEN was filed as Word mark on 12/27/2001 at the U.S. Patent and Trademark Office. The current status of the mark is "ABANDONED - AFTER EX PARTE APPEAL".

Trademark Details Last update: May 19, 2018

Trademark form Word mark
File reference 76354586
Application date December 27, 2001

Trademark owner

Frankfurter StraBe 250
D-64293 Darmstadt
DE

Trademark representatives

goods and services

5 Pharmaceutical and biopharmaceutical products for the treatment of cancer, MDS, genetic disorders and immunological disorders; novel protein drugs for use in the area of oncology, immune therapies and for the treatment of metabolic disorders
42 Scientific research and development in the area of pharmacy, medicine, biology and genetics, developing treatments for serious and life-threatening diseases as well as broad technology platforms that will lead to new therapies

ID: 1376354586